APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Colorectal Cancer Screening Tests

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

Selected research

Industry Growth & Trends

Global In-Vitro Colorectal Cancer Screening Tests Industry Growth and Trends Forecast to 2032

Report ID 173894510126 December 2025102 pages

Choose your research edition.

Industry ResearchIn-Vitro Colorectal Cancer Screening Tests Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Colorectal Cancer Screening Tests Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal In-Vitro Colorectal Cancer Screening Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Colorectal Cancer Screening Tests Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Colorectal Cancer Screening Tests Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

According to APO Research, the global In-Vitro Colorectal Cancer Screening Tests market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global In-Vitro Colorectal Cancer Screening Tests market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The In-Vitro Colorectal Cancer Screening Tests market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global In-Vitro Colorectal Cancer Screening Tests market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to In-Vitro Colorectal Cancer Screening Tests.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global In-Vitro Colorectal Cancer Screening Tests market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

In-Vitro Colorectal Cancer Screening Tests Market by Company

Alere(Abbott)

Beckman Coulter

Siemens Healthcare

Eiken Chemical

Hitachi Chemical (Kyowa Medex)

Clinical Genomics Pty Ltd (Quest Diagnostics)

Sysmex

QIAGEN

R-Biopharm

Immunostics

In-Vitro Colorectal Cancer Screening Tests Segment by Type

Biomarker Tests

Fecal Occult Blood Tests

CRC DNA Screening Tests

In-Vitro Colorectal Cancer Screening Tests Segment by Application

Hospital and Clinics

Ambulatory

Home Care

In-Vitro Colorectal Cancer Screening Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Colorectal Cancer Screening Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Colorectal Cancer Screening Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Colorectal Cancer Screening Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Colorectal Cancer Screening Tests Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2021-2026) & (US$ Million) Table 3. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2021-2026) Table 4. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2027-2032) & (US$ Million) Table 5. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2027-2032) Table 6. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2026) & (US$ Million) Table 8. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2026) Table 9. Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share Forecasted by Type (2027-2032) Table 11. North America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2026) & (US$ Million) Table 23. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2026) Table 24. Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share Forecasted by Application (2027-2032) Table 26. North America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. In-Vitro Colorectal Cancer Screening Tests Industry Trends Table 37. In-Vitro Colorectal Cancer Screening Tests Industry Drivers Table 38. In-Vitro Colorectal Cancer Screening Tests Industry Opportunities and Challenges Table 39. In-Vitro Colorectal Cancer Screening Tests Industry Restraints Table 40. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Company (US$ Million) & (2021-2026) Table 41. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Company (2021-2026) Table 42. Global In-Vitro Colorectal Cancer Screening Tests Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global In-Vitro Colorectal Cancer Screening Tests Key Company Headquarters & Area Served Table 44. Global In-Vitro Colorectal Cancer Screening Tests Company, Product Type & Application Table 45. Global In-Vitro Colorectal Cancer Screening Tests Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global In-Vitro Colorectal Cancer Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Alere(Abbott) Company Information Table 49. Alere(Abbott) Business Overview Table 50. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 52. Alere(Abbott) Recent Development Table 53. Beckman Coulter Company Information Table 54. Beckman Coulter Business Overview Table 55. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 57. Beckman Coulter Recent Development Table 58. Siemens Healthcare Company Information Table 59. Siemens Healthcare Business Overview Table 60. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 62. Siemens Healthcare Recent Development Table 63. Eiken Chemical Company Information Table 64. Eiken Chemical Business Overview Table 65. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 67. Eiken Chemical Recent Development Table 68. Hitachi Chemical (Kyowa Medex) Company Information Table 69. Hitachi Chemical (Kyowa Medex) Business Overview Table 70. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 72. Hitachi Chemical (Kyowa Medex) Recent Development Table 73. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information Table 74. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview Table 75. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 77. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development Table 78. Sysmex Company Information Table 79. Sysmex Business Overview Table 80. Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 82. Sysmex Recent Development Table 83. QIAGEN Company Information Table 84. QIAGEN Business Overview Table 85. QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 87. QIAGEN Recent Development Table 88. R-Biopharm Company Information Table 89. R-Biopharm Business Overview Table 90. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 92. R-Biopharm Recent Development Table 93. Immunostics Company Information Table 94. Immunostics Business Overview Table 95. Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 97. Immunostics Recent Development Table 98. North America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026) & (US$ Million) Table 100. North America In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2026) Table 101. North America In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Country (2027-2032) Table 103. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2026) Table 106. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2026) Table 111. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Country (2027-2032) Table 113. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2026) Table 116. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2026) Table 121. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. In-Vitro Colorectal Cancer Screening Tests Product Image Figure 3. Global In-Vitro Colorectal Cancer Screening Tests Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032) & (US$ Million) Figure 5. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region: 2025 VS 2032 Figure 6. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2021-2032) Figure 7. North America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Biomarker Tests Image Figure 13. Global Biomarker Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Fecal Occult Blood Tests Image Figure 15. Global Fecal Occult Blood Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. CRC DNA Screening Tests Image Figure 17. Global CRC DNA Screening Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global In-Vitro Colorectal Cancer Screening Tests Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Type 2025 VS 2032 Figure 20. North America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2032) Figure 21. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2032) Figure 23. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2032) Figure 25. Hospital and Clinics Image Figure 26. Global Hospital and Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Ambulatory Image Figure 28. Global Ambulatory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Home Care Image Figure 30. Global Home Care Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global In-Vitro Colorectal Cancer Screening Tests Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Application 2025 VS 2032 Figure 33. North America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2032) Figure 34. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2032) Figure 36. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 In-Vitro Colorectal Cancer Screening Tests Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America In-Vitro Colorectal Cancer Screening Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032) Figure 43. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032) Figure 46. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032) Figure 49. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032) Figure 52. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Biomarker Tests
  • Fecal Occult Blood Tests
  • CRC DNA Screening Tests
Applications
  • Hospital and Clinics
  • Ambulatory
  • Home Care
Companies covered
  • Alere(Abbott)
  • Beckman Coulter
  • Siemens Healthcare
  • Eiken Chemical
  • Hitachi Chemical (Kyowa Medex)
  • Clinical Genomics Pty Ltd (Quest Diagnostics)
  • Sysmex
  • QIAGEN
  • R-Biopharm
  • Immunostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2021-2032)
  5. 1.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2021-2026)
  6. 1.4.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2027-2032)
  7. 1.5 Key Regions In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
  8. 1.5.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (2021-2032)
2 In-Vitro Colorectal Cancer Screening Tests Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Biomarker Tests
  3. 2.1.2 Fecal Occult Blood Tests
  4. 2.1.3 CRC DNA Screening Tests
  5. 2.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type
  6. 2.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Regions
  10. 2.3.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Type (2021-2026)
3 In-Vitro Colorectal Cancer Screening Tests Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital and Clinics
  3. 3.1.2 Ambulatory
  4. 3.1.3 Home Care
  5. 3.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application
  6. 3.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Regions
  10. 3.3.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
  2. 4.2 In-Vitro Colorectal Cancer Screening Tests Industry Drivers
  3. 4.3 In-Vitro Colorectal Cancer Screening Tests Industry Opportunities and Challenges
  4. 4.4 In-Vitro Colorectal Cancer Screening Tests Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by In-Vitro Colorectal Cancer Screening Tests Revenue (2021-2026)
  2. 5.2 Global In-Vitro Colorectal Cancer Screening Tests Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global In-Vitro Colorectal Cancer Screening Tests Key Company Headquarters & Area Served
  4. 5.4 Global In-Vitro Colorectal Cancer Screening Tests Company, Product Type & Application
  5. 5.5 Global In-Vitro Colorectal Cancer Screening Tests Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global In-Vitro Colorectal Cancer Screening Tests Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 In-Vitro Colorectal Cancer Screening Tests Players Market Share by Revenue in 2025
  9. 5.6.3 2025 In-Vitro Colorectal Cancer Screening Tests Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Alere(Abbott)
  2. 6.1.1 Alere(Abbott) Company Information
  3. 6.1.2 Alere(Abbott) Business Overview
  4. 6.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  6. 6.1.5 Alere(Abbott) Recent Developments
  7. 6.2 Beckman Coulter
  8. 6.2.1 Beckman Coulter Company Information
  9. 6.2.2 Beckman Coulter Business Overview
  10. 6.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  12. 6.2.5 Beckman Coulter Recent Developments
  13. 6.3 Siemens Healthcare
  14. 6.3.1 Siemens Healthcare Company Information
  15. 6.3.2 Siemens Healthcare Business Overview
  16. 6.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  18. 6.3.5 Siemens Healthcare Recent Developments
  19. 6.4 Eiken Chemical
  20. 6.4.1 Eiken Chemical Company Information
  21. 6.4.2 Eiken Chemical Business Overview
  22. 6.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  24. 6.4.5 Eiken Chemical Recent Developments
  25. 6.5 Hitachi Chemical (Kyowa Medex)
  26. 6.5.1 Hitachi Chemical (Kyowa Medex) Company Information
  27. 6.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
  28. 6.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  30. 6.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
  31. 6.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
  32. 6.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information
  33. 6.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
  34. 6.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  36. 6.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
  37. 6.7 Sysmex
  38. 6.7.1 Sysmex Company Information
  39. 6.7.2 Sysmex Business Overview
  40. 6.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  42. 6.7.5 Sysmex Recent Developments
  43. 6.8 QIAGEN
  44. 6.8.1 QIAGEN Company Information
  45. 6.8.2 QIAGEN Business Overview
  46. 6.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  48. 6.8.5 QIAGEN Recent Developments
  49. 6.9 R-Biopharm
  50. 6.9.1 R-Biopharm Company Information
  51. 6.9.2 R-Biopharm Business Overview
  52. 6.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  54. 6.9.5 R-Biopharm Recent Developments
  55. 6.10 Immunostics
  56. 6.10.1 Immunostics Company Information
  57. 6.10.2 Immunostics Business Overview
  58. 6.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  60. 6.10.5 Immunostics Recent Developments
7 North America
  1. 7.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
  3. 7.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
  3. 8.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
  3. 10.3 South America In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst